A study published in Science has revealed important information about a brain receptor known as  mGlyR, which could be a potential antidepressant target. An abbreviation of “metabotropic glycine receptor,” mGlyR is highly active in the brain’s medial prefrontal cortex (mPFC). Abnormal activity in the brain region is associated with depression. Formerly known as GPR158, mGlyR … Continue reading Study suggests mGlyR could be a promising antidepressant target